Abstracts by key term: Saxony-Thuringia Medicines Initiative
With the end of the maximum legally possible term of eight years, the ARMIN model project, the Saxony-Thuringia pharmaceutical initiative, was ended on June 30, 2022. This means that a promising and now even positively evaluated care approach, which promotes and interlinks interprofessional collaboration between doctors and pharmacists for the benefit of the patient population being cared for together, is on the brink of extinction. It is no wonder that the actors used the opportunity when the evaluation data was presented to put forward political demands in order to maintain the positive effects of ARMIN beyond the end of the project and possibly even further develop them, although in the opinion of the ARMIN- Project partners must first create the necessary legal basis.